All terms in EFO
| Label | Id | Description |
|---|---|---|
| triacylglycerol 50:5 measurement | EFO_0010412 | [The quantification of triacylglycerol 50:5 levels in some body fluid, used as a biomarker for disease.] |
| hereditary hemochromatosis | MONDO_0006507 | [An inherited metabolic disorder characterized by iron accumulation in the tissues.] |
| hemosiderosis | MONDO_0001436 | [Accumulation of iron in internal organs.] |
| inborn metal metabolism disorder | MONDO_0004689 | [An inherited metabolic disorder that involves metabolic disturbances in the processing or distribution of dietary minerals.] |
| disorder of iron metabolism and transport | MONDO_0017763 | |
| Yersinia enterocolitica infectious disease | EFO_0009424 | [Infections with bacteria of the species Yersinia enterocolitica.] |
| Yersinia infectious disease | EFO_1001245 | [Infections with bacteria of the genus Yersinia., Infections with bacteria of the genus yersinia.] |
| triacylglycerol 52:1 measurement | EFO_0010413 | [The quantification of triacylglycerol 52:1 levels in some body fluid, used as a biomarker for disease.] |
| Yersinia pestis infectious disease | EFO_0009425 | [Infections with bacteria of the species Yersinia pestis., Plague is a severe bacterial infection caused by the gram-negative bacterium Yersinia pestis.] |
| primary bacterial infectious disease | MONDO_0000314 | |
| vector-borne disease | MONDO_0100120 | [An infectious disease where a pathogen is carried and transmitted by another organism that acts as disease vector.] |
| triacylglycerol 50:3 measurement | EFO_0010410 | [The quantification of triacylglycerol 50:3 levels in some body fluid, used as a biomarker for disease.] |
| triacylglycerol 50:4 measurement | EFO_0010411 | [The quantification of triacylglycerol 50:4 levels in some body fluid, used as a biomarker for disease.] |
| necrosis | EFO_0009426 | [The phenotypic observation that death has occurred in groups of cells or in one or more tissues due to external factors, such as infection, toxins, mechanical trauma, loss of blood supply and other injuries (e.g. corrosion or burning). At the cellular level, morphological changes following necrosis include a translucent cytoplasm, swelling of organelles, modifications of the nucleus and increased cell volume (oncosis), culminating in the disruption of the plasma membrane and subsequent loss of intracellular contents. Necrotic cells do not fragment into discrete corpses as their apoptotic counterparts do. Moreover, their nuclei remain intact and can aggregate and accumulate in necrotic tissues.] |
| Phenotypic abnormality | HP_0000118 | [A phenotypic abnormality.] |
| septum of telencephalon | UBERON_0000446 | [Gray matter structure located on the midline of the forebrain consisting of the septum pellucidum (in some species) and the septal nuclei (Heimer, 1996).] |
| cerebral hemisphere | UBERON_0001869 | [One of two bilateral, largely symmetrical organ subdivisions within the telencephalon which contain the cerebral cortex and cerebral white matter.[FMA].] |
| central nervous system | UBERON_0001017 | [The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the neural tube derivatives: the brain and spinal cord. In invertebrates it includes central ganglia plus nerve cord.] |
| forebrain | UBERON_0001890 | [The most anterior region of the brain including both the telencephalon and diencephalon.] |
| telencephalon | UBERON_0001893 | [Part of the forebrain consisting of paired olfactory bulbs and cerebral hemispheres.] |